Detalhe da pesquisa
1.
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
Cell
; 184(15): 3962-3980.e17, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171305
2.
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.
Blood
; 139(15): 2306-2315, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167655
3.
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated Individuals.
Clin Infect Dis
; 75(1): e869-e873, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278306
4.
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies.
JCO Precis Oncol
; 8: e2300349, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237098
5.
Rapid Quantum Magnetic IL-6 Point-of-Care Assay in Patients Hospitalized with COVID-19.
Diagnostics (Basel)
; 12(5)2022 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626318
6.
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma.
Nat Med
; 28(9): 1848-1859, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097221
7.
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.
Blood Adv
; 6(6): 1671-1683, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073571
8.
SARS -CoV-2 T-cell immunity to variants of concern following vaccination.
bioRxiv
; 2021 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972942
9.
Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients.
Leukemia
; 36(4): 1176-1179, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217807